Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acceptability crossover study of Zindaclin versus other topical antibiotics in mild to moderate acne
ISRCTN43187439Phase 4Completed
- Sponsor
- ProStrakan
- Start
- Feb 2002
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of clindamycin, erythromycin + benzoyl peroxide and erythromycin + zinc acetate in acne vulgaris, sponsored by ProStrakan. Primary endpoint: Patient Acceptability Questionnaire. Started Feb 2002; status: completed.
02
Drugs
clindamycinerythromycin + benzoyl peroxideerythromycin + zinc acetate
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on ISRCTN43187439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN43187439.